SCHEMBL23249103

SCHEMBL23249103

CN(C)CCn1ccc(C(F)(F)F)cc1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.44
HTR2A P28223 3/20 0.44
DRD3 P35462 2/20 0.42
DRD2 P14416 1/20 0.42
TP53 P04637 2/20 0.40
CTSK P43235 2/20 0.40
NPC1 O15118 1/20 0.40
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
ABCB1 P08183 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CYP2D6 P10635 1/20 0.40
CHRM1 P11229 1/20 0.40
TSHR P16473 1/20 0.40
DRD1 P21728 1/20 0.40
TBXA2R P21731 1/20 0.40
SLC6A2 P23975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13243615 0.80 DRD2 (0.42) DRD3DRD2TP53MAPTLMNA
SCHEMBL7163458 0.78 DRD2 (0.50) DRD3DRD2TP53TSHRMAPT
SCHEMBL25997014 0.77 KCNH2 (0.41) HTR2CHTR2ADRD3DRD2TP53
SCHEMBL18914238 0.77 HTR2C (0.49) HTR2CHTR2ADRD3DRD2HTR1D
SCHEMBL23956117 0.76 HTR2C (0.60) HTR2CHTR2ADRD3TP53NPC1
SCHEMBL16064395 0.76 HTR2C (0.44) HTR2CHTR2AHTR1DROS1ALK
SCHEMBL3658413 0.76 HTR2C (0.44) HTR2CHTR2AHTR1D
SCHEMBL2001744 0.75 DRD2 (0.47) DRD3DRD2TSHRMAPTLMNA
SCHEMBL16423236 0.75 MAPT (0.39) DRD3DRD2TP53TSHRMAPT
SCHEMBL22971668 0.74 HTR2C (0.43) HTR2CHTR2AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021076902-A1 INHIBITING HUMAN INTEGRIN α 4 β 7 MORPHIC THERAPEUTIC, INC. (US) 2021-04-22 WO disclosed